+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Proteomic Analysis of Dynein-Interacting Proteins in Amyotrophic Lateral Sclerosis Synaptosomes Reveals Alterations in the RNA-Binding Protein Staufen1

Proteomic Analysis of Dynein-Interacting Proteins in Amyotrophic Lateral Sclerosis Synaptosomes Reveals Alterations in the RNA-Binding Protein Staufen1

Molecular and Cellular Proteomics 15(2): 506-522

Synapse disruption takes place in many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). However, the mechanistic understanding of this process is still limited. We set out to study a possible role for dynein in synapse integrity. Cytoplasmic dynein is a multisubunit intracellular molecule responsible for diverse cellular functions, including long-distance transport of vesicles, organelles, and signaling factors toward the cell center. A less well-characterized role dynein may play is the spatial clustering and anchoring of various factors including mRNAs in distinct cellular domains such as the neuronal synapse. Here, in order to gain insight into dynein functions in synapse integrity and disruption, we performed a screen for novel dynein interactors at the synapse. Dynein immunoprecipitation from synaptic fractions of the ALS model mSOD1(G93A) and wild-type controls, followed by mass spectrometry analysis on synaptic fractions of the ALS model mSOD1(G93A) and wild-type controls, was performed. Using advanced network analysis, we identified Staufen1, an RNA-binding protein required for the transport and localization of neuronal RNAs, as a major mediator of dynein interactions via its interaction with protein phosphatase 1-beta (PP1B). Both in vitro and in vivo validation assays demonstrate the interactions of Staufen1 and PP1B with dynein, and their colocalization with synaptic markers was altered as a result of two separate ALS-linked mutations: mSOD1(G93A) and TDP43(A315T). Taken together, we suggest a model in which dynein's interaction with Staufen1 regulates mRNA localization along the axon and the synapses, and alterations in this process may correlate with synapse disruption and ALS toxicity.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058652737

Download citation: RISBibTeXText

PMID: 26598648

DOI: 10.1074/mcp.M115.049965

Related references

Proteomic analysis reveals differentially regulated protein acetylation in human amyotrophic lateral sclerosis spinal cord. Plos One 8(12): E80779, 2014

Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. Journal of Proteome Research 14(11): 4486-4501, 2016

Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. Free Radical Biology and Medicine 38(7): 960-968, 2005

Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. Journal of Biological Chemistry 278(8): 6371-6383, 2002

Expression of beta-amyloid precursor protein, prion protein, and alpha-1-antichymotrypsin mRNAs in spinal cords of amyotrophic lateral sclerosis and non-amyotrophic lateral sclerosis controls. Neurology 46(2 SUPPL ): A346, 1996

The essential and downstream common proteins of amyotrophic lateral sclerosis: A protein-protein interaction network analysis. Plos One 12(3): E0172246, 2017

Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 1(8): 544-553, 2014

Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord. Febs Journal 276(12): 3308-3323, 2009

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis. Experimental and Therapeutic Medicine 11(6): 2095-2106, 2016

Alfa-class prefoldin protein UXT is a novel interacting partner of Amyotrophic Lateral Sclerosis 2 (Als2) protein. Biochemical and Biophysical Research Communications 413(3): 471-475, 2011

Studies on amyotrophic lateral sclerosis by neutron activation analysis 3. systematic analysis of metals on guamanian amyotrophic lateral sclerosis and parkinsonism dementia complex cases. Folia Psychiatrica et Neurologica Japonica 36(2): 173-180, 1982

Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders. Dementia and Geriatric Cognitive Disorders 44(3-4): 144-152, 2017

Protein folding alterations in amyotrophic lateral sclerosis. Brain Research 1648(Pt B): 633-649, 2016

Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 9(6): 339-349, 2008

Proteomic analysis in the SOD-1 G93A mouse model of human amyotrophic lateral sclerosis. Journal of Neurochemistry 78(Supplement 1): 130, September, 2001